Now there’s a simple, non-invasive exhaled breath test to help clarify if respiratory symptoms are due to allergic asthma and require inhaled corticosteroids, or if symptoms are caused by something else.

A new report shows that a group of leaders in the field of asthma recommend measuring exhaled nitric oxide (also sometimes called FENO–fractional exhaled nitric oxide) as part of the standard care for asthma patients. The study was conducted last summer at National Jewish Health and was funded by Aerocrine; this posting was not paid for by either source.

Click here to read the Consensus Statement on the Use of Fractional Exhaled Nitric Oxide (FENO) in the Management of Asthma, or to request a copy of the complete paper.

---

Related posts:

1. New Asthma Test: Will It Help You Breathe Easier?
2. AANMA and National Jewish Health Partner to help clean up the air in your home
3. Calling Volunteers in Baltimore, Chicago and Richmond, VA!

We rely on your donations to bring more content please click here to help